“…Such an achievement would involve the transport of the nanoparticulate therapeutics, from the luminal to the basolateral sides of the brain vascular system across the endothelial cells, if such a transport system can be designed. Ultrasmall superparamagnetic iron oxide nanoparticles (USPIO NPs) are particularly promising devices since their magnetic properties increase the number of possible applications in many areas of the biomedical field, including drug delivery, thermotherapy, imaging and detection of cancer. , However, their potential and pathways to cross biological barriers, including the blood–brain barrier (BBB) and the blood–brain tumor barrier (BBTB) needs to be confirmed if they are to be used in the diagnosis and therapy of brain diseases and brain tumors. − Previous studies, including ours, have addressed the translocation of NPs of various compositions across cell layers using two-compartments devices separated by a polymeric membrane, but these previous studies have used only one type of cells and did not demonstrate a very efficient transport, possibly because of the characteristics of the polymeric membrane separating the two compartments. − Only one previous study has suggested, using a three-cell coculture model of the lung including epithelial cells, macrophages and dendritic cells, that macrophages and dendritic cells can exchange 1 μm polystyrene NPs via cell extended cytoplasmic processes across the epithelial layer. However, these cells belong to the immune phagocytic lineage and the mechanisms involved need to be defined.…”